Dec 13, 2019 / 01:00PM GMT
Sabah Oney - Alector, Inc. - Chief Business Officer
Good morning, everybody. Thank you all for being here. We're very appreciative of all of you that are here in person in a packed room and for those of you that are dialing in, really appreciate especially potentially from West Coast, 5 am in the morning. So let's get this started. I'm Sabah, I'm the Chief Business Officer at Alector, and I've been with the team for about 4 years now, and welcome to our first, and what we hope to be, Annual Research and Development Day.
I will be your MC. I'll kick things off. And quickly, I'll be handing it over to Arnon, who's our CEO and Co-Founder.
Really quickly. The speakers today are Arnon; Robert Paul, who is our Chief Medical Officer, I'll do a quick section on the corporate strategy. And then we have 3 key opinion leaders in neurodegeneration. Dr. Masellis from Sunnybrook Health Sciences Centre; Dr. Bradshaw from Columbia University; and Dr. Cruchaga from Washington University in St. Louis. They will be going over specific sections in our presentation as well and giving you the research
Alector, Inc. - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
